title: The effect of intermittent hypoxia on bodyweight, serum glucose and cholesterol in obesity mice.
abstract: This article tests mice's indicators of body nutritional metabolism under tolerable hypoxic conditions, in order to explore the effects of moderate intermittent hypoxia on the bodyweight, blood sugar and blood cholesterol of obese mice and to identify the role of leptin in these effects; this study applies high-fat diet to establish Mice Obesity Models and observes the intervention effects of intermittent hypoxic training in this Model. Small healthy mice are classified in 4 groups at random, that is, Group A (Normal), Group B (Normal Hypoxia) fed with normal foods and undergoing Intermittent Hypoxic Training (IHT), Group C (Fatty-diet) fed with High-Fat and High-Sugar (HFHS) foods without IHT and Group D (Fatty-diet and Hypoxia) fed with HFHS foods with IHT. After 40 days of feeding and hypoxic training, weigh the mice, measure the levels of blood sugar and blood cholesterol with a full automatic biochemical analyzer, measure serum leptin concentration by enzyme-linked immunosorbent assay (ELISA) technique, inspect liver leptin receptor expression and liver fat slice by immunohistochemistry. It is found that compared to control group, after experiment, the average bodyweight, blood sugar, blood cholesterol and serum leptin concentration in Group C is increased significantly and numerous fat cells are distributed in the liver, which indicates that hyperlipemia model has been successfully established; after intermittent hypoxic training, the average bodyweight, blood sugar, blood cholesterol and liver fat cells distribution density and scope in Group B and D are lower than those in Group A and C, while serum leptin concentration is increased significantly; liver leptin receptor expression in Group D is higher than that in Group C. And hypoxia groups have no trauma conclusion. Moderate intermittent hypoxia can reduce bodyweight by increasing leptin concentration and enhancing liver leptin expression and it can also reduce the level of blood sugar and blood cholesterol and meanwhile prevent steatosis in liver cells effectively.
authors.affiliation: Clinical Medicine, Xiangya Medical School, Central South University, China.
authors.forename: Qin
authors.initials: Q
authors.lastname: Ling
authors.forename: Wen
authors.initials: W
authors.lastname: Sailan
authors.forename: Jing
authors.initials: J
authors.lastname: Ran
authors.forename: Song
authors.initials: S
authors.lastname: Zhi
authors.forename: Li
authors.initials: L
authors.lastname: Cen
authors.forename: Xiang
authors.initials: X
authors.lastname: Yang
authors.forename: Qin
authors.initials: Q
authors.lastname: Xiaoqun
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D001835:Body Weight; D002784:Cholesterol / Q000378:metabolism*; D005260:Female; D000860:Hypoxia; D020738:Leptin / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D051379:Mice; D008954:Models, Biological; D009765:Obesity / Q000235:genetics*; D010100:Oxygen / Q000378:metabolism; D011312:Pressure; D054411:Receptors, Leptin / Q000378:metabolism; D014018:Tissue Distribution
chemical_list: D001786:Blood Glucose; D020738:Leptin; D054411:Receptors, Leptin; D002784:Cholesterol; D010100:Oxygen